Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764130011 | Dolasetron mesilate 20 mg powder for solution for injection ampoule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3764131010 | Dolasetron mesylate 20 mg powder for solution for injection ampule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3764132015 | Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Is a | Dolasetron only product in parenteral dose form | true | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has presentation strength denominator unit | Ampoule | true | Inferred relationship | Some | 1 | |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has presentation strength numerator value | 20 | false | Inferred relationship | Some | 1 | |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has precise active ingredient | Dolasetron mesylate | true | Inferred relationship | Some | 1 | |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has BoSS | Dolasetron mesylate | true | Inferred relationship | Some | 1 | |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has unit of presentation | Ampoule | true | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Plays role | Antiemetic therapeutic role | true | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Is a | Dolasetron-containing product | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has active ingredient | Dolasetron | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Is a | Dolasetron-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has active ingredient | Dolasetron mesylate | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Dolasetron mesilate 20 mg powder for solution for injection ampoule | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR